2[1]Hahn SA,Schutte M,Hoque AT,Moskaluk CA,da Costa LT,Rozenblum E,Weinstein CL,Fischer A,Yeo CJ,Hruban RH,Kern SE.DPC4,a candidate tumor suppressor gene at human chromosome 18q21.1.Science 1996; 271:350-353
3[2]Ijichi H,Ikenoue T,Kato N,Mitsuno Y,Togo G,Kato J,Kanai F,Shiratori Y,Omata M.Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells.Biochem Biophys Res Commun 2001; 289:350-357
4[3]Bartsch D,Barth P,Bastian D,Ramaswamy A,Gerdes B,Chaloupka B,Deiss Y,Simon B,Schudy A.Higher frequency of DPC4/Smad4 alterations in pancreatic cancercell lines than in primary pancreatic adenocarcinomas.Cancer Lett 1999; 139:43-49
5[4]Maurice D,Pierreux CE,Howell M,Wilentz RE,Owen MJ,Hill CS.Loss of Smad4 function in pancreatic tumors:C-terminal truncation leads to decreased stability.J Biol Chem 2001; 276:43175-43181
6[5]Moren A,Hellman U,Inada Y,Imamura T,Heldin CH,Moustakas A.Differential ubiquitination defines the functional status of the tumor suppressor Smad4.J Biol Chem 2003; 278:33571-33582
7[6]Moore PS,Sipos B,Orlandini S,Sorio C,Real FX,Lemoine NR,Gress T,Bassi C,Kloppel G,Kalthoff H,Ungefroren H,Lohr M,Scarpa A.Genetic profile of 22 pancreatic carcinoma cell lines.Analysis of K-ras,p53,p16 and DPC4/ Smad4.Virchows Arch 2001; 439:798-802
8[7]Koyama M,Ito M,Nagai H,Emi M,Moriyama Y.Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers:identification of seven novel somatic mutations in tumors from Japanese patients.Mutat Res 1999; 406:71-77
9[8]Ju HR,Jung U,Sonn CH,Yoon SR,Jeon JH,Yang Y,Lee KN,Choi I.Aberrant signaling of TGF-betal by the mutant Smad4 in gastric cancer cells.Cancer Lett 2003; 196:197-206
10[9]Woodford-Richens K,Williamson J,Bevan S,Young J,Leggett B,Frayling I,Thway Y,Hodgson S,Kim JC,Iwama T,Novelli M,Sheer D,Poulsom R,Wright N,Houlston R,Tomlinson I.Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium.Cancer Res 2000; 60:2477-2482
2Ktster F, Schr6er A, Fischer D, et al. Immunohistochemistry of proteins for DNA mismatch repair in correlation to prognostic factors of mammarian cancer [ J ]. Oncol Rep,2007,17 (5) : 1223 -1227.
3Elston CW, Ellis IO. Pathological prognostic factors in breast canc- er. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up [ J ]. Histopathology, 1991,19(5) :403-410.
4Greenspan DI, Connolly DC, Wu R, et al. Loss of FHIT expres- sion in cervical carcinoma cell lines and primary tumors [ J ]. Cancer Res, 1997,57 (21) : 46924698.
5Back MJ, Kang H, Kim SE, et al. Expression of hMLH1 is inacti- vated in the gastric adenomas with enhanced microsatellite instabil- ity[J]. Br J Cancer,2001,85(8) :1147-1152.
6Thykjaer T, Christensen M, Clark AB, et al. Functional analysis of the mismatch repair systemin bladder cancer[ J]. Br J Cancer, 2001,85(4) : 568-575.
7Kuismanen SA, Hohnberg MT, epigenetic modification of MLH1 Salovaara R, et al. Genetic and accounts for a major share of mic- rosatellite-unstable colorectal cancers[ J]. AmJ Pathol,2000,156 (5) :1773-1779.
